Results 41 to 50 of about 139,619 (346)
High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
Cancer Management and Research, 2020 Daolin Si,1 Fei Yin,1 Jing Peng,1 Guangying Zhang2 1Department of Pediatric Neurology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, People’s Republic of China; 2Department of Oncology, Xiangya Hospital, Central South
Si D, Yin F, Peng J, Zhang G
doaj
Clinical, Cosmetic and Investigational Dermatology, 2022 Yalan Bi,1 Xiaohua Shi,2 Dian Chen,1 Yi Zhao1 1Department of Dermatology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, People’s Republic of China; 2Department of Pathology, Peking Union Medical College ...
Bi Y, Shi X, Chen D, Zhao Y
doaj
Chinese Journal of Lung Cancer, 2021 Background and objective Small cell lung cancer (SCLC) is a highly aggressive malignancy characterized by rapid growth, early metastasis and acquired therapeutic resistance, and the prognosis is extremely poor.
Ying WANG +9 more
doaj +1 more source
The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
Frontiers in Oncology, 2019 Background: CD44 is widely used as a putative cancer stem cells (CSCs) marker for colorectal cancer (CRC). However, the prognostic role of CD44 in CRC remains controversial.
semanticscholar +1 more source
Silencing of CD44 Expression in Prostate Cancer by Hypermethylation of the CD44 Promoter Region [PDF]
Laboratory Investigation, 2000 Loss of the CD44 transmembrane glycoprotein in primary prostate cancer has been shown to be associated with unfavorable clinical behavior. Moreover, the majority of prostate cancer metastases lack expression of this molecule. The mechanism of CD44 silencing in prostate cancer was investigated using both patient material and in vivo-propagated human ...
M J Bussemakers +4 more
openaire +3 more sources
International Journal of Nanomedicine, 2020 Rui Yang,1,* Mudan Lu,2,* Lan Ming,1,* Yu Chen,1 Kai Cheng,1 Jie Zhou,1 Shiwen Jiang,1 Zhenyu Lin,3 Daozhen Chen1 1Research Institute for Reproductive Health and Genetic Diseases, Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing ...
Yang R +8 more
doaj
CD44: expanding the toolKIT [PDF]
Blood, 2018 Expanding the universe of mast cell diseases beyond tyrosine kinase inhibitors, in this issue of Blood, Mueller et al find that the invasion receptor CD44 is both a biomarker of and potential therapeutic target for mast cell neoplasms ...
openaire +3 more sources
Theranostics, 2019 Silicosis is pneumoconiosis of the lung, usually resulting from prolonged exposure to crystalline silica (CS). The hallmark of silicosis is excessive extracellular matrix (ECM) deposition produced by activated fibroblasts.
Siyi Li +8 more
semanticscholar +1 more source
Arthritis research & therapy, 2003 CD44 is a multistructural cell-surface glycoprotein that can theoretically generate close to 800 isoforms by differential alternative splicing. At present, several dozen isoforms are known. The polymorphic nature of CD44 might explain its multifunctionality and its ability to interact with many cell-surface and extracellular ligands, the principal one ...
Shlomo Nedvetzki, David Naor
openaire +3 more sources
The Serum Assay of Soluble CD44 Standard, CD44 Variant 5, and CD44 Variant 6 in Patients with Gastric Cancer [PDF]
Cancer Research and Treatment, 2003 Alternative splicing of CD44 and aberrant levels of soluble CD44 (sCD44) protein in the serum of cancer patients has been correlated to tumor progression and metastasis. The purpose of this study was to evaluate the concentrations, and the prognostic potential of sCD44s, sCD44v5 and sCD44v6, in patients with gastric cancer.The serum levels of sCD44s ...
Sung Hoon Noh, Chang Hak Yoo
openaire +3 more sources